Samit Hirawat
Fortune : 2 M $ au 31/08/2026
Fortune : 2 M $ au 31/08/2026
Dr. Samit Hirawat, MD, is an Independent Director at Pacira Biosciences, Inc. and an Operating Partner at Jeito Capital /US/.
He is on the Board of Directors at Pacira Biosciences, Inc. Dr. Hirawat was previously employed as a Chief Medical Officer, EVP & Head-Development by Bristol Myers Squibb Co. and a Head- Global Oncology Development by Novartis AG.
He received his undergraduate degree from SMS Medical College & Hospital.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/03/2026 | 31 925 ( 0% ) | 2 M $ | 31/08/2026 | |
| 10/06/2026 | 6 405 ( 0,02% ) | 165 890 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| PACIRA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 27/01/2026 |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Directeur/Membre du Conseil | 01/08/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Directeur Technique/Scientifique/R&D | 01/08/2025 |
| NOVARTIS AG | Corporate Officer/Principal | 01/06/2019 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Pacira Biosciences, Inc.
Pacira Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures injectable therapeutic products | Health Technology |
SMS Medical College & Hospital
SMS Medical College & Hospital Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national